Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:FFM
ASX:FFMMetals and Mining

How Investors Are Reacting To FireFly Metals (ASX:FFM) Sharply Narrowing Its Half-Year Net Loss

FireFly Metals Ltd recently reported half-year results to December 31, 2025, reducing its net loss to A$727,000 from A$5.73 million and cutting basic loss per share from A$0.011 to A$0.0011 year-on-year. This sharp improvement in profitability metrics, while still loss-making, points to operational progress that may reshape how investors assess the company’s progress. We’ll now examine how FireFly Metals’ sharply reduced half-year loss might influence its investment narrative and future...
XTRA:AIXA
XTRA:AIXASemiconductor

Assessing AIXTRON (XTRA:AIXA) Valuation As AI Driven GaN And SiC Orders Gain Traction

Why renewed AI demand is putting AIXTRON (XTRA:AIXA) in focus Recent reports of increased orders for AIXTRON (XTRA:AIXA) GaN and SiC production equipment, tied to AI power electronics and AI server infrastructure, have put fresh attention on the stock ahead of its 26 February 2026 earnings update. See our latest analysis for AIXTRON. AIXTRON’s share price has picked up momentum recently, with a 7 day share price return of 7.33%, a 30 day gain of 22.86% and a 90 day move of 36.38%. This has...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide And Uber Test Robotaxi Economics With Abu Dhabi Expansion

WeRide (NasdaqGM:WRD) and Uber are expanding their commercial Robotaxi service into downtown Abu Dhabi. The rollout connects major tourism and business districts and is part of a plan to deploy 1,200 autonomous vehicles across the Middle East by 2027. For you as an investor, this development puts WeRide directly into the conversation around real-world, commercial autonomous driving at scale, not just pilots or tests. The expansion with Uber into Abu Dhabi’s busy core highlights how...
TSE:4516
TSE:4516Pharmaceuticals

Assessing Nippon Shinyaku’s Valuation After Mixed Nine Month Earnings And New Full Year Guidance

Why Nippon Shinyaku’s latest results matter for shareholders Nippon Shinyaku (TSE:4516) has just reported nine month results to December 31, 2025, with higher sales but lower net income year on year, and issued fresh full year guidance through March 31, 2026. For investors, the combination of revenue growth, profit pressure and new management signals from the latest board meeting provides a basis for reassessing how the stock’s current valuation aligns with these updated numbers. See our...
NYSE:KD
NYSE:KDIT

A Look At Kyndryl Holdings (KD) Valuation After Filing Delays Are Resolved And Controls Plan Outlined

Kyndryl Holdings (KD) has been back in focus after submitting its delayed quarterly and annual filings. The company outlined a remediation plan for internal controls and confirmed that no corrections to previously filed 2025 quarterly results are required. See our latest analysis for Kyndryl Holdings. The filings news comes after a sharp reset in expectations, with a 30 day share price return of 48.0% and a year to date share price return of 48.5%, alongside a 1 year total shareholder return...
TSE:9960
TSE:9960Trade Distributors

Assessing Totech (TSE:9960) Valuation After New Share Buyback And Revised Earnings Guidance

Totech’s new buyback and earnings guidance put capital allocation in focus Totech (TSE:9960) has caught investor attention after its board authorized a new share repurchase program alongside updated earnings guidance for the fiscal year ending March 2026. This signals fresh decisions around capital use and profit outlook. See our latest analysis for Totech. The announcement of a ¥774.9 million buyback at ¥4,305 per share and updated earnings guidance comes after a 30 day share price return of...
TSX:MG
TSX:MGAuto Components

Why Magna International (TSX:MG) Is Up 16.9% After Raising Its Dividend And Issuing 2026 Sales Guidance – And What's Next

In February 2026, Magna International Inc. reported fourth-quarter 2025 sales of US$10,848 million with a small net loss, issued 2026 sales guidance of US$41.90 billion to US$43.50 billion, raised its quarterly dividend to US$0.495 per share for a 16th consecutive year of fourth-quarter increases, and updated its ongoing share repurchase activity. Together, the steady dividend growth, disciplined buybacks, and detailed 2026 sales outlook suggest management is emphasizing capital returns and...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

A Look At Power Integrations (POWI) Valuation After Mixed Results Cost Cuts And Leadership Changes

Power Integrations (POWI) has been in focus after a cluster of updates, including mixed quarterly results, new revenue guidance, a 7% workforce reduction, a board reshuffle and an upcoming dividend payment. See our latest analysis for Power Integrations. Those mixed earnings, new revenue guidance, workforce reduction and board changes come after a sharp 48.54% 90 day share price return and a 23.14% year to date share price return, set against a 27.44% 1 year total shareholder return decline...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Assessing Netflix (NFLX) Valuation After Recent Multi‑Period Share Price Declines

Context around recent Netflix performance Without a specific news catalyst, Netflix (NFLX) is drawing attention after a recent share price slide, with the stock showing negative returns over the past month, the past 3 months, year to date, and over the past year. See our latest analysis for Netflix. At a share price of US$77.99, Netflix’s recent 30 day share price return of 11.38% decline and 90 day share price return of 26.19% decline contrast with a 3 year total shareholder return of...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Does S&P SmallCap 600 Entry And Parkinson’s Deal Reshape The Bull Case For Amneal Pharmaceuticals (AMRX)?

Amneal Pharmaceuticals, Inc. announced that it has been added to the S&P SmallCap 600 Index and, in a separate move, entered into a research collaboration and option agreement with KeifeRx to develop KFRX06, a preclinical candidate targeting the LRRK2 gene linked to Parkinson's disease. These developments could broaden Amneal’s investor base through index inclusion while expanding its neuroscience pipeline via early-stage Parkinson’s research. Next, we’ll explore how joining the S&P SmallCap...
BIT:TEN
BIT:TENEnergy Services

Tenaris (BIT:TEN) Valuation Check After Q4 2025 Results And Dividend Proposal

Tenaris (BIT:TEN) shares are reacting to fresh fourth quarter and full year 2025 results, with steady sales in core regions, resilient margins under 50% Section 232 tariffs, and a proposed annual dividend drawing investor attention. See our latest analysis for Tenaris. The latest earnings release and dividend proposal appear to have given fresh momentum to Tenaris, with a 30 day share price return of 17.35% and year to date share price return of 28.19%. The 5 year total shareholder return of...
TSE:2602
TSE:2602Food

A Look At Nisshin OilliO GroupLtd (TSE:2602) Valuation After Nine Month Results And Updated Guidance

Why Nisshin OilliO GroupLtd (TSE:2602) Is Back on Investor Radars Nisshin OilliO GroupLtd (TSE:2602) has drawn fresh attention after releasing nine month results to December 31, 2025, alongside new full year guidance and a reaffirmed dividend, giving investors several new data points to assess. See our latest analysis for Nisshin OilliO GroupLtd. The latest nine month results, earnings call, full year guidance and dividend affirmation have landed against a backdrop of steady momentum, with a...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

AXT Faces Ownership Shift As Revenue Recovers Under Export Restrictions

Pacific Ridge Capital Partners has fully exited its position in AXT (NasdaqGS:AXTI), removing a major institutional shareholder from the register. The divestment comes shortly after AXT reported a revenue turnaround at a time when the company is facing headwinds from China related export restrictions. This shift in ownership occurs as AXT continues to operate under heightened policy and trade scrutiny that directly affects parts of its business. AXT, which supplies compound semiconductor...
NYSE:AM
NYSE:AMOil and Gas

A Look At Antero Midstream (AM) Valuation After Strong Q4 2025 Beat And Optimistic 2026 Outlook

Why Antero Midstream (AM) is back in focus Antero Midstream (AM) is drawing attention after reporting Q4 2025 results that topped forecasts, with adjusted net income, EBITDA and free cash flow after dividends all higher, alongside 2026 guidance calling for double digit net income growth. See our latest analysis for Antero Midstream. Those Q4 2025 results, the 2026 net income guidance of US$485 million to US$535 million, and recent buybacks land against a strong run, with a 14.65% 1 month...
NYSE:GLW
NYSE:GLWElectronic

Corning (GLW) Valuation Check As AI Optical Growth And Meta Deal Fuel Strong Share Price Momentum

Corning (GLW) is back in focus after its Optical Communications sales rose 35% in 2025, supported by enterprise spending tied to Generative AI and carrier demand for data center connectivity. See our latest analysis for Corning. The stock has been on a strong run, with a 40.14% 1 month share price return and 69.18% 3 month share price return, alongside a very large 1 year total shareholder return of 155.40%. This suggests momentum has been building around Corning's data center and AI related...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Microsoft’s US$50b AI Push Reshapes Global South And Valuation Story

Microsoft (NasdaqGS:MSFT) has announced a $50b AI investment initiative focused on building infrastructure across the Global South. The plan was outlined at an AI summit in New Delhi and targets AI data centers, connectivity, and local ecosystem support in developing regions. In parallel, Microsoft is shifting toward AI self-sufficiency by developing its own models and chips and expanding intellectual property rights in its reworked OpenAI partnership. Microsoft, trading at around $399.6...
NYSE:CF
NYSE:CFChemicals

A Look At CF Industries (CF) Valuation After Its Stronger Than Expected Q4 Earnings And Revenue Results

Why CF Industries Holdings (CF) just caught the market’s attention CF Industries Holdings (CF) reported fourth quarter and full year 2025 results with higher sales and net income versus the prior year, along with adjusted earnings that topped analyst expectations despite a US$76 million asset impairment. See our latest analysis for CF Industries Holdings. The earnings beat and higher reported sales and net income sit alongside a strong 90 day share price return of 23.18% and a 1 year total...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron Pharmaceuticals (REGN) Valuation Check After New Allergy Pipeline Results And AAAAI 2026 Abstracts

Regeneron Pharmaceuticals (REGN) recently highlighted 36 abstracts from its immunology and inflammation pipeline for the 2026 AAAAI meeting, including Phase 3 data on allergen specific antibody cocktails for cat and birch allergy related eye symptoms. See our latest analysis for Regeneron Pharmaceuticals. Against this backdrop, Regeneron’s recent AAAAI abstracts come as the share price sits at US$792.16, with a 30 day share price return of 8.06% and a 1 year total shareholder return of...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium (CSTM) Margin Compression To 1.4% Tests Bullish Profitability Narratives

Constellium FY 2025 Results: Revenue Steady, Earnings Volatile Constellium (CSTM) just posted another quarter of mixed numbers, with Q3 2025 revenue at US$2.2b, basic EPS of US$0.63 and net income of US$88m. The latest trailing twelve month figures show revenue of about US$8.0b and EPS of US$0.80 alongside a net margin of 1.4% compared to 1.8% the prior year. Over recent quarters, the company has seen revenue move from US$1.8b in Q3 2024 to US$2.2b in Q3 2025. Quarterly EPS has swung from a...
NYSE:WSO
NYSE:WSOTrade Distributors

Is It Time To Reassess Watsco (WSO) After Its Recent Share Price Rebound

If you are wondering whether Watsco's current share price reflects its true worth, this article walks through the key numbers that matter for valuation. Watsco shares last closed at US$419.32, with returns of 9.9% over the past 30 days, a 20.7% gain year to date, but a 15.7% decline over the past year and gains of 48.5% and 94.7% over the last 3 and 5 years respectively. Recent attention on Watsco has been driven by ongoing coverage of the business and its position in the capital goods...
ENXTBR:ABI
ENXTBR:ABIBeverage

A Look At Anheuser Busch InBev (ENXTBR:ABI) Valuation After Results Dividend Proposal And Share Buyback

Why Anheuser-Busch InBev (ENXTBR:ABI) Is Back on Investors’ Radar Anheuser-Busch InBev (ENXTBR:ABI) is drawing fresh attention after releasing its fourth quarter and full year 2025 results, proposing a full year dividend of €1.15 per share, and completing a $635 million share buyback. See our latest analysis for Anheuser-Busch InBev. Those earnings, dividend and buyback announcements have landed alongside strong recent momentum, with a 30 day share price return of 15.06% and a 90 day share...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Assessing Jack Henry (JKHY) Valuation After Analyst Upgrades Dividend Increase And Blue Sky Bank Win

Why Jack Henry & Associates (JKHY) is back in focus Recent analyst sentiment around Jack Henry & Associates (JKHY) has turned more constructive, coinciding with fresh news on its dividend policy, share repurchases, and a new client relationship with Blue Sky Bank. This mix of capital returns and business wins gives you several concrete data points to consider as you think about how JKHY fits into a portfolio focused on financial technology and payment services. See our latest analysis for...
NYSE:MD
NYSE:MDHealthcare

A Look At Pediatrix Medical Group (MD) Valuation After Earnings Show Lower Sales But Stronger Profitability

Why Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings per share, catching investor attention as the market absorbs this mixed top and bottom line picture. See our latest analysis for Pediatrix Medical Group. The latest move in Pediatrix Medical Group’s share price to US$21.97 comes after a year where shorter term share price returns were mixed, while the 1 year...
NYSE:CBZ
NYSE:CBZProfessional Services

CBIZ Buyback Authorization Raises Fresh Questions On Valuation And Debt

CBIZ (NYSE:CBZ) has authorized a new share repurchase program for up to 5,000,000 shares. The new authorization follows the expiration of the company’s previous buyback plan. The announcement reflects a fresh capital allocation decision focused on returning capital to shareholders. CBIZ provides professional services, including financial, insurance and advisory solutions, which tie closely to corporate spending, regulatory needs and risk management. When a company in this space refreshes...